Into 2019: Intelligent Innovation's Role In The Shape Of Medtech Things To Come
Brexit, the "Implant Files" and the new EU regulations – however large they loom at present, they will in time be seen as mere tactical challenges for a global medtech industry working hard to ensure that it is ready for the massive health-care delivery and service-oriented changes to come. Preparing for the future and maximizing current market penetration – in the UK, the EU and beyond – were key themes at UK HealthTech 2018, held in Cardiff, Wales.
You may also be interested in...
The UK continues to build its digital health care infrastructure, as seen in the recent funding pledge for a new AI Lab. Andrew Davies is the newly appointed digital health lead at the UK’s ABHI medtech industry association. He says stakeholders first need to understand the scope of digital health care, and then adopt a networked approach, with medtech playing a full part in that evolution.
The UK continues to build its digital health-care infrastructure, as seen in last week’s government funding pledge for a new AI lab. But this is set against criticism of the lack of digital resources at health-care providers. As the ABHI’s newly appointed digital health lead, Andrew Davies says stakeholders first need to understand the scope and needs of digital health care, and then adopt a networked approach, with medtech playing a full part in the helping the system evolve appropriately.
Europe's biggest medtech industry and market, Germany, was in the crosshairs of the "Implant Files" and its ICIJ reporters, and predictably it caused a major stir. The episode has been a wake-up call for medtech, but industry hasn't let it develop into the crisis it briefly threatened to become, and is now looking beyond it and to the commercial challenges of 2019.